VP research and development Front Range BIosciences
Front Range Biosciences

Reginal Gaudino

Dr. Reggie Gaudino is a molecular geneticist focused on biochemical networks in plant phytochemistry. He received his PhD from the Roswell Park Cancer Institute division of SUNY @ Buffalo. Dr. Gaudino was able to use his scientific knowledge of the burgeoning biotechnology field to crossover into the also new arena of biotech patent litigation and spent the next 22 years working as a patent scientist or Patent Agent both in the biotech sector and with a number of national law firms, including Lead Scientist for the Litigation support team in an early, highly publicized, plant biotechnology patent litigation. Dr. Gaudino reentered the scientific arena armed with a deep understanding of intellectual property and commercial laboratory testing methodology by joining the first and at one time largest commercial Cannabis testing lab in the US and likely the world, Steep Hill, Inc. At Steep Hill, Dr. Gaudino assembled a team of scientists that went on to introduce the first DNA based diagnostic assay for Cannabis under the Genkit name, Genkit-SexID, followed by the first DNA based diagnostic for high CBD producing varieties. Now at Front Range Biosciences as the VP of Research and Development and Director of IP, Dr. Gaudino manages a team of scientists, field agronomists, breeders, and growers that carry out sophisticated breeding programs for hemp and cannabis, directed by multidisciplinary scientific support. Dr. Gaudino and his team have contributed to the general body of knowledge for this under-studied model organism, through several peer-reviewed scientific publications.

This site uses cookies. By using this site or closing this notice, you agree to the use of cookies and ourĀ privacy policy.